Archive | November, 2013

Stealth Sell-Off in Biotech Stocks: AEGR, INCY, MDVN, REGN, PCYC Update 2 11/8

http://revueplanches.com/calendar/action~month/tag_ids~39/ Strong Jobs Report Boosts Market–Treasuries Sell -Off with 10 Year up to 2.74% Volatile Week Finds Buyers-Technical Levels Hold 11/8/13 9:45 a Biotechnology stocks rebounded today with the IBB up 3% to $203.86. The sector hit a major downdraft yesterday but we are still well above Q3 lows (IBB)  on October 9. The rebound is […]

Continue Reading 0

Rayno Biopharmaceutical Update: CBST,IMGN,REGN,VPHM and Large Caps Rule

provigil to buy Biotech Remains Strong But Momentum Is Easing Biotechnology stocks were positive today but major ETFs mixed with the FBT ($63.82) off 1.45%.  Profit taking has hit some high fliers (AEGR,INCY) and many of our portfolio stocks are off their recent highs. Small and mid-caps are being sold off harder than larger caps with revenues and […]

Continue Reading 0

Rayno Biopharmaceutical Portfolio Nov. 1, 2013 YTD Performance…Update 1

http://restginhisshadow.com/tag/christmas/?http://faithfulbloggers.co Updated 2/11/15 see chart below Rayno 2013 Picks Outperform Biotechnology Indices and Funds  Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%, IBB ($206) up 50%, and XBI ((%120) up 36%. The Five Star Fidelity Select Biotechnology Fund (FBIOX $171) is up 54.5% YTD. You […]

Continue Reading 0

Rayno Life Science Scoreboard- October 2013- Amidst Sell-Off

Equities:  The Only Game in Town With Rates Under 3%? October, normally a month to be cautious on the market, proved that trends can be misleading even in the midst of turbulent times in Washington. DOW Up 2.5%, S&P Up 3.5%, NASDAQ Up 2.5%. Healthcare stocks followed suit with the broadly diversified NYSE  SPDR ETV (XLV) up […]

Continue Reading 0